Clinical trial · Interventional
The Development of an In-vitro System to Identify Gynecologic Cancer Cells During Surgical Procedures
NCT02718209CI-TRIAL-00021488unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine the efficacy of mid-infrared spectroscopy together with Attenuated Total Reflection (ATR), for the detection of gynecological malignancies in real time during surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecological Malignancies | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mid-Infrared Spectroscopy with ATR | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Frozen section
- description
- Frozen sections taken from women operated on for possible gynecologic malignancies.
- interventionNames
- Device: Mid-Infrared Spectroscopy with ATR
Primary outcomes (1)
- measure
- Gynecological Malignancies Identified in Real Time
- timeFrame
- One hour
- description
- Results of Spectroscopy will be compared to frozen section/histopathology findings
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women with one or more tumors in reproductive system Exclusion Criteria: * Pregnant women * Unable to give consent
References
Publications (0)
Data not yet available
No reference posted for this study.